
Juan Pascual
Chief, Pediatric Neurology · Cornell Univ Joan and Sanford I Weill Med Coll
Credentials: · · ·
History
PresentPediatric Neurology Division · Cornell Univ Joan and Sanford I Weill Med Coll
PresentRare Brain Disorders Program · University of California (San Diego) Medical Center
PresentNew York Presbyterian Hospital · Cornell Univ Joan and Sanford I Weill Med Coll

The University
- 1986–1990
University of Granada School of Medicine
Research
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas
Nature Medicine · 2012 · 652 citations
Cell Metabolism · 2012 · 447 citations
Metabolism of [U-13 C]glucose in human brain tumors in vivo
NMR in Biomedicine · 2012 · 309 citations

20 papers
- VJ
19 papers · 1 as a resident

13 papers · 10 as a resident

12 papers

11 papers

8 papers

8 papers

7 papers
Grants
- 2024–2029
Mechanisms of Motor Superperformance
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.7M · Weill Medical Coll of Cornell Univ
- 2023–2029
Brain Glucose Deficiency: Mechanisms and Modulation
National Institute of Neurological Disorders and Stroke · RM1
Contact PI · $5.3M · Weill Medical Coll of Cornell Univ
- 2024–2025
The 11th International Glut1 Deficiency Summit
National Institute of Neurological Disorders and Stroke · R13
Contact PI · $5K · Weill Medical Coll of Cornell Univ
- 2017–2023
Pyruvate Dehydrogenase Encephalopathy: Mechanisms and Therapy
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.8M · Ut Southwestern Medical Center
Clinical trials
- 2027–2031
Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome
Principal investigator · Suspended
Weill Medical College of Cornell University
- 2018–2022
Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
- 2018–2023
Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
- 2017


